Does Anthem Cover Dupixent?
The verdict
Covered on most plans
Anthem (Elevance Health) covers Dupixent on the specialty tier with prior authorization and step therapy via CarelonRx across commercial, Medicare Advantage, and Medicaid lines. Dupixent is usually a self-injected pharmacy-benefit (Part D) drug dispensed through CarelonRx specialty pharmacy, but it can shift to the medical benefit when administered in a clinical setting. Expect 25-33% coinsurance until the applicable out-of-pocket cap; commercially insured patients can use the Dupixent MyWay copay card.
Coverage is set by your specific plan and formulary. This is a research summary — always confirm with Anthem using your member ID.
Key facts
Dupixent (dupilumab) is approved by the FDA for six indications: atopic dermatitis (age 6 months+), moderate-to-severe asthma (age 6+), chronic rhinosinusitis with nasal polyps, eosinophilic esophagitis, prurigo nodularis, and COPD with eosinophilic phenotype.
FDA drug labeling — Dupixent (dupilumab), Sanofi/Regeneron
Approximately 79% of Medicare Part D Dupixent recipients pay $0-$100 per month under post-Inflation Reduction Act cost-sharing protections, according to Sanofi/Regeneron patient access data.
Sanofi/Regeneron — Dupixent MyWay patient access data
Anthem (Elevance Health) operates as a BCBS licensee in 14 states and uses CarelonRx as its pharmacy benefit manager for specialty drug management.
Anthem/Elevance Health — CarelonRx pharmacy benefit information
Medicare vs. commercial coverage
Whether Anthem covers Dupixent depends heavily on which kind of plan you hold. They follow completely different rules — here's each one, side by side.
Medicare
Part D & Advantage plans
Medicare Advantage and Part D plans managed by Anthem: Dupixent is on the specialty tier with PA and indication-specific step therapy. Members pay approximately 25-33% coinsurance after the deductible, capped at $2,100 for 2026 — after which the plan pays 100% for the rest of the year. Per Sanofi/Regeneron, about 79% of Medicare Part D Dupixent recipients pay $0-$100 per month under the post-IRA catastrophic protections. The Dupixent MyWay copay card cannot be used by Medicare beneficiaries. When Dupixent is administered in a clinical setting, it may be billed under Medicare Part B (medical benefit) rather than Part D.
Commercial / Employer
Group & marketplace plans
Commercial/Employer plans: Dupixent is covered on the specialty tier (Tier 4 or 5) with PA and indication-specific step therapy via CarelonRx. For atopic dermatitis, step therapy typically requires documented failure of topical therapies (corticosteroids, calcineurin inhibitors) and often a trial of a systemic agent; for asthma, trials of preferred biologics such as Xolair, Tezspire, or Nucala. Specialty-pharmacy dispensing is required through CarelonRx's contracted specialty network. The Dupixent MyWay copay card (Sanofi/Regeneron) can reduce cost to as little as $0 for eligible commercially insured patients. ACA/Individual marketplace Anthem plans cover Dupixent on the specialty tier with PA where offered. Medicaid: Anthem-managed Medicaid covers Dupixent for approved indications per state PDL with PA and step therapy; nominal cost-share ($0-$4). Medical vs. pharmacy benefit: Dupixent is primarily a pharmacy-benefit self-injected drug; can flip to Part B/medical benefit when clinic-administered.
The 5 boxes you must tick to get approved
Commercial plans that will consider Dupixent require prior authorization. Check off what applies to you to see how close you are — this is a guide, not a guarantee of approval.
Meet all 5 and you have a documented case for approval. Missing any one is the most common reason requests are denied.
Your cost, three ways
What Dupixent actually costs you swings enormously depending on how it's covered. Here's the realistic range.
Paying cash
Approximately $3,993 per carton of 2 pre-filled pens (list price, Jan 2025 estimate); average retail approximately $5,350-$5,377 per month (estimate). All cash figures are estimates — verify current pricing before use.
List price with no coverage — before any manufacturer savings card.
With coverage
Commercial specialty tier: typically 25-33% coinsurance (composite range; exact coinsurance depends on Anthem plan design). Medicare Advantage/Part D: approximately 25-33% coinsurance after deductible, capped at $2,100 for 2026. Medicaid: $0-$4 nominal cost-share. Confirm actual cost-share on your plan's Summary of Benefits.
Typical monthly copay once prior authorization is approved.
Bridge program
Dupixent MyWay copay program (Sanofi/Regeneron): as little as $0 per month for eligible commercially insured patients. Not available to Medicare, Medicaid, or other government-plan beneficiaries. Enroll at dupixent.com/myway or call 1-844-DUPIXENT.
Reduced copay through the assistance program, where eligible.
All copay figures are estimates and vary by individual Anthem plan design, state, and CarelonRx formulary tier. Verify exact cost-share by calling the member services number on your insurance card or using Anthem's online cost-estimator tool.
Check YOUR exact coverage in 3 steps
General answers only get you so far. Here's how to confirm your own plan's decision in a few minutes.
- 1
Search Dupixent on Anthem's drug-lookup tool or CarelonRx formulary
Log into your Anthem member portal (anthem.com) and use the drug-lookup or formulary search tool. Search for both 'Dupixent' and 'dupilumab.' Note the tier, any PA or step-therapy requirement, and the CarelonRx specialty pharmacy designation. The exact tier varies across Anthem's commercial, Medicare, and Medicaid lines.
- 2
Have your specialist initiate a Prior Authorization through CarelonRx
Your allergist, dermatologist, pulmonologist, or gastroenterologist initiates the PA. Gather clinical documentation: diagnosis, prior treatment history (step-therapy evidence), current disease severity, and supporting lab values (e.g., eosinophil count for asthma). Your physician's office typically submits the PA to CarelonRx directly.
- 3
Enroll in Dupixent MyWay if you are commercially insured
If Anthem approves Dupixent but your coinsurance is still high, enroll in the Dupixent MyWay copay program at dupixent.com/myway. For Medicare beneficiaries, explore Medicare Extra Help (Low Income Subsidy) for additional cost-share assistance — the manufacturer card cannot be used on government plans.
Options if Anthem won't cover Dupixent
A denial isn't the end of the road. These are the paths people commonly explore next — discuss any of them with your prescriber.
Topical corticosteroids and calcineurin inhibitors
For atopic dermatitis: step-therapy agents required before Dupixent. Medium-to-high potency topical steroids and tacrolimus/pimecrolimus are typically the first-line standard-of-care agents; PA criteria at CarelonRx generally require documented failure of these agents.
Xolair (omalizumab), Nucala (mepolizumab), Tezspire (tezepelumab)
For asthma: depending on the eosinophil phenotype, CarelonRx plans may require trials of one or more of these preferred asthma biologics before approving Dupixent. Step-therapy sequence is indication-specific and plan-specific.
Rinvoq (upadacitinib) or Cibinqo (abrocitinib) — JAK inhibitors
For atopic dermatitis in adults: JAK inhibitors are sometimes listed as preferred alternatives or required step-therapy agents before Dupixent on some Anthem plans. Discuss with your dermatologist whether a JAK inhibitor trial is required by your specific plan.
These options are listed for information only — your own clinician decides what is appropriate for you.
❓Frequently Asked Questions
Yes, Anthem (Elevance Health) covers Dupixent on the specialty tier with prior authorization and indication-specific step therapy via CarelonRx, across commercial, Medicare Advantage, and Medicaid lines. Coverage is broad; the barriers are administrative (PA, step therapy) and cost-related (25-33% coinsurance). Verify the exact tier and step-therapy requirements on your specific Anthem plan using the online drug-lookup tool or by calling CarelonRx.
Step therapy requirements vary by indication. For atopic dermatitis, Anthem/CarelonRx typically requires documented failure of topical corticosteroids and, in some cases, a systemic agent. For asthma, trials of preferred biologics — Xolair, Nucala, or Tezspire — may be required depending on eosinophil phenotype and plan. Your prescriber's prior-authorization submission must include clinical notes documenting these prior treatment steps.
With Anthem commercial insurance, expect specialty-tier coinsurance of approximately 25-33% — which can be reduced to as low as $0 with the Dupixent MyWay copay card for eligible commercially insured patients. On Anthem Medicare Advantage or Part D, coinsurance is approximately 25-33% after the deductible, capped at $2,100 for 2026; about 79% of Medicare Part D recipients on Dupixent pay $0-$100 per month per Sanofi/Regeneron. Medicaid members pay nominal cost-share.
Yes, Anthem covers Dupixent for all its FDA-approved indications — including atopic dermatitis (age 6 months+) and moderate-to-severe asthma (age 6+) — subject to prior authorization and indication-specific step therapy. Dupixent is also approved for chronic rhinosinusitis with nasal polyps, eosinophilic esophagitis, prurigo nodularis, and COPD with eosinophilic phenotype; PA criteria differ by indication.
Dupixent is primarily a self-injected pharmacy-benefit (Part D) drug dispensed through CarelonRx specialty pharmacy. However, when Dupixent is administered by a clinician in an office or infusion-center setting, it can shift to the medical benefit and be billed under Part B for Medicare members, or under the medical cost-share for commercial plans. Most patients self-inject at home under the pharmacy benefit.
Related Articles
Does Aetna Cover Vyvanse? 2026 CVS Caremark Formulary
Aetna covers Vyvanse via CVS Caremark — generic lisdexamfetamine preferred, brand non-preferred. 70 mg/day QL per Policy 5.60.024; age-22 PA required.
Read moreDoes Aetna Cover Prolia? CVS Caremark Medical Benefit | Curex
Aetna covers Prolia under the medical benefit with PA — a q6-month clinic injection, not Part D. Jubbonti biosimilar now preferred on CVS Caremark.
Read moreDoes Anthem Cover Adderall? 2026 Coverage Guide | Curex
Anthem covers Adderall through CarelonRx — generic preferred, brand non-preferred. Step therapy may apply on some plans. Verify your Anthem plan.
Read moreDoes Anthem Cover Contrave? 2026 Brand Coverage Guide | Curex
Anthem covers Contrave only if your plan has a weight-loss benefit. Many plans carve it out. CurAccess ~$99/mo is often the fastest path.
Read moreDoes Aetna Cover Contrave? 2026 CVS Caremark Guide | Curex
Aetna (CVS Caremark) often excludes Contrave under AOM carve-outs. Where covered, CVS BMI prior auth applies. Medicare bars it by law. CurAccess ~$99/mo.
Read moreDoes Aetna Cover Forteo? 2026 Coverage Guide
Aetna (CVS) often excludes brand Forteo in favor of generic teriparatide or Bonsity. Teriparatide is covered with PA and bisphosphonate step therapy. 2026.
Read moreThis content is for informational purposes only and does not constitute medical, financial, or insurance advice. Coverage rules, prior-authorization criteria, and copay amounts change frequently and vary by plan, formulary tier, and effective date — always verify current benefits directly with Anthem before making any decision. Consult a licensed healthcare provider and your plan administrator for guidance specific to your situation.